Free shipping on all orders over $ 500

Glucosylceramide synthase-IN-2

Cat. No. M21070
Glucosylceramide synthase-IN-2  Structure
Synonym:

T-690

Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Glucosylceramide-IN-2 (T-690) is a potent, blood-brain barrier-transparent and orally active inhibitor of glucosylceramide synthase (GCS) with IC50s of 15 nM and 190 nM for human GCS and mouse GCS, respectively. basal and non-competitive with UDP-glucose.

Chemical Information
Molecular Weight 447.41
Formula C22H20F3N3O4
CAS Number 2597958-02-4
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Mariko Komuro, et al. Biochem Biophys Res Commun. Glucosylceramide in T cells regulates the pathology of inflammatory bowel disease

[2] Ivan Milenkovic, et al. Curr Opin Neurobiol. GBA mutations, glucosylceramide and Parkinson's disease

[3] Catherine Viel, et al. Sci Rep. Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model

[4] Jian Gan, et al. Acta Biochim Pol. The role of glucosylceramide and glucosylceramide synthase in liver disease: from bench to bedside - Review

[5] Maria C Messner, et al. Adv Exp Med Biol. Glucosylceramide in humans

Related Glucosylceramide Synthase Products
G43

G43 is a potent, selective glucosyltransferase inhibitor, with the Kd of 3.7μM and 46.9 nM for GtfB and GtfC, respectively.

Glucosylceramide synthase-IN-1 

Glucosylceramide synthase-IN-1 (T-036) a potent, brain-penetrant and orally active glucosylceramide synthase (GCS) inhibitor with IC50s of 31 nM and 51 nM for human GCS and mouse GCS, respectively. Glucosylceramide synthase-IN-1 can be used for Gaucher's disease research.

D-threo-PDMP 

D-threo-PDMP is a potent glucoceramide synthase (GCS) inhibitor, which reduces the glycosphingolipids on the cell surface by inhibiting glycosylation, reduces the total length of the axon plexus and the number of axon branch points, and inhibits neurite growth.

Lucerastat

Lucerasta is the galactose form of Miglustat, an orally active inhibitor of glucosylceramide synthase (GCS).Lucerastat has potential for use in Fabry disease research.

Ibiglustat (L-Malic acid)

Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: Glucosylceramide synthase-IN-2 , T-690 supplier, Glucosylceramide Synthase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.